Bothersome urinary symptoms and disease-specific quality of life in patients with benign prostatic obstruction

References

• Trueman P, Hood SC, Nayak USL, Mrazek MF. Prevalence of lower urinary tract symptoms and self-reported diagnosed “benign prostatic hyperplasia” and their effect on quality of life in a community-based survey of men in the UK. BJU Int 1999; 83: 410–5
   PubMed Web of Science ®Google Scholar
• Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs FDR, Fourcade R, et al. The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study. BJU Int 2003; 92: 409–14
   PubMed Web of Science ®Google Scholar
• Andersson S-O, Rashidkhani B, Karlberg L, Wolk A, Johansson J-E. Prevalence of lower urinary tract symptoms in men aged 45–79 years: a population-based study of 40 000 Swedish men. BJU Int 2004; 94: 327–31
   PubMed Web of Science ®Google Scholar
• Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167–78
   PubMed Web of Science ®Google Scholar
• Eckhardt M, vanVenrooij G, Van Melick H, Boon T. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being. J Urol 2001; 166: 563–8
   PubMed Web of Science ®Google Scholar
• Barry MJ. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am 1990; 17: 495–507
   PubMed Web of Science ®Google Scholar
• Blanker MH, Groeneveld FPMJ, Prins A, Bernsen RMD, Bohnen AM, Bosch JLHR. Strong effects of definition and nonresponse bias on prevalence rates of clinical prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status. BJU Int 2000; 85: 665–71
   PubMed Web of Science ®Google Scholar
• Donovan JL, Brookes ST, de la Rosette JJMCH, Peters TJ, Porru D, Kondo A, et al. The responsiveness of the ICSmale questionnaire to outcome: evidence from the ICS-“BPH” study. BJU Int 1999; 83: 243–8
   PubMed Web of Science ®Google Scholar
• Barry MJ. Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia. Urology 2001; 58(Suppl 6A)25–32
   PubMed Web of Science ®Google Scholar
• Malmsten U, Milsom I, Molander U, Norlen LJ. Urinary incontinence and lower urinary tract symptoms: an epidemiological study of men aged 45 to 99 years. J Urol 1997; 158: 1733–7
   PubMed Web of Science ®Google Scholar
• Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs FDR, Fourcade R, et al. The prevalence of male urinary incontinence in four centres: the UREpik study. BJU Int 2003; 92: 943–7
   PubMed Web of Science ®Google Scholar
• AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 3: Results of the treatment outcomes analyses. Available from: http://www.auanet.org/guidelines/bph.cfm.
   Google Scholar
• Haltbakk J, Hanestad BR, Hunskaar S. Diversity of urinary symptoms in patients tentatively diagnosed with benign prostatic hyperplasia referred to a urologic clinic in Norway. Scand J Urol Nephrol 2004; 38: 454–61
   PubMed Web of Science ®Google Scholar
• Barry MJ, Fowler FJ, Jr, O'Leary MP, Bruskewitz RC, Holtgrewe LH, Mebust WK, et al. Measuring disease-specific health status in men with benign prostatic hyperplasia. Med Care 1995; 33(Suppl 4)145–55
   PubMed Web of Science ®Google Scholar
• Chapple CR. Introduction. Urology 2003; 62(Suppl 3A)1–5
   PubMed Web of Science ®Google Scholar
• Hald T. Urodynamics in benign prostate hyperplasia. A survey. Prostate 1989; 2: 69–77
   Google Scholar
• Folkestad B, Spångberg A. Timed micturition and maximum urinary flow rate in randomly selected symptom-free males. Scand J Urol Nephrol 2004; 38: 136–42
   PubMed Web of Science ®Google Scholar
• Folkestad B, Spångberg A. Validation of timed micturition. Scand J Urol Nephrol 2004; 38: 385–90
   PubMed Web of Science ®Google Scholar
• Barry MJ, Fowler FJ, Jr, O'Leary MP, Bruskewitz RC, Holtgreve HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 1549–57
   PubMed Web of Science ®Google Scholar
• Burns N, Grove SK. The practice of nursing research: conduct, critique, and utilization5th edn. Elsevier Saunders, St. Louis, MO 2005; 374, 415–6
   Google Scholar
• Reuterberg S-E. Hantering av bortfall i longitudinella studier, ett exempel. Pedagogisk forskning i Sverige 2001; 3: 173–94
   Google Scholar
• Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297–334
   Web of Science ®Google Scholar
• Hansen MV, Zdanowski A, Spångberg A. Prostatism symptoms in a randomly selected population: introduction of a patient administered population based symptom evaluation score. Scand J Urol Nephrol 1994; 28: 371–8
   PubMed Web of Science ®Google Scholar
• Badía X, García-Losa M, Dal-Ré R. Ten-Language translation and harmonization of the international prostate symptom score: developing a methodology for multinational clinical trials. Eur Urol 1997; 31: 129–40
   PubMed Web of Science ®Google Scholar